Secondary Offering for Medical Transcription Billing, Corp.

(Est. Date 06/23/2017)

Medical Transcription Billing, Corp., together with its consolidated subsidiaries (the “Company”), is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform is designed to help our clients increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs.

The company is offering up to 340,000 shares of our 11% Series A Cumulative Redeemable Perpetual Preferred Stock, which is referred to as the Series A Preferred Stock. Dividends on the Series A Preferred Stock offered hereby are cumulative from the first day of the calendar month in which they are issued, and will be payable on the fifteenth day of each calendar month, when, as and if declared by our board of directors. Dividends will be payable out of amounts legally available therefor at a rate equal to 11% per annum per $25.00 of stated liquidation preference per share, or $2.75 per share of Series A Preferred Stock per year. Commencing on November 4, 2020, we may redeem, at our option, the Series A Preferred Stock, in whole or in part, at a cash redemption price of $25.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. The Series A Preferred Stock has no stated maturity, will not be subject to any sinking fund or other mandatory redemption, and will not be convertible into or exchangeable for any of our other securities. Holders of the Series A Preferred Stock generally will have no voting rights except for limited voting rights if dividends payable on the outstanding Series A Preferred Stock are in arrears for eighteen or more consecutive or non-consecutive monthly dividend periods.

Show More
This information has been gathered from the company's offering prospectus.

Secondary Offering Documentation

Loading...

Key Secondary Offering Data

MTBCP
NASDAQ
$8,500,000
340,000
Rodman & Renshaw
This information has been gathered from the company's offering prospectus.

How Does a Secondary Offering Work?

Open a Motif Account

Open a brokerage account to get ready for trading.

Participate in an Offering

Review secondary offering pricing, prospectus, and other documentation.

Place a Conditional Order

Select an investment amount and fund the secondary offering.

Receive Your Offering Shares

View your allocated shares on account positions page.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date.